Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Leukaemia Section Short Communication t(8;21)(q23;q22) Jean-Loup Huret Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France (JLH) Published in Atlas Database: October 2008 Online updated version : http://AtlasGeneticsOncology.org/Anomalies/t0821q23q22ID1271.html DOI: 10.4267/2042/44589 This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. © 2009 Atlas of Genetics and Cytogenetics in Oncology and Haematology Clinics and pathology Disease Result of the chromosomal anomaly Refractory anaemia with excess of blasts (RAEB) Hybrid gene Epidemiology Transcript Breakpoints in RUNX1 exon 6 and ZFPM2 exon 6. Both reciprocal transcripts are expressed. Only one case to date, a 78 year old male patient (Chan et al., 2005). Fusion protein Genes involved and proteins Description 1242 amino acids (aa) protein, composed of aa 1 to 268 from RUNX1 and aa 178 to 1151 from ZFPM2. Oncogenesis NH2 RUNX1 - ZFPM2 COOH fuses the DNA binding domain of RUNX1 to most of ZFPM2 (including the 8 zinc finger domains and the corepressor C-term binding domain), and represses the transcriptional activity of the core binding factor (CBF, the dimer made of RUNX1 (CBFA2) and CBFB) and GATA1. The reciprocal ZFPM2-RUNX1 may also reduce the transcriptional activity of the normal RUNX1 allele. ZFPM2/FOG2 Location 8q23 Protein ZFPM2, better known as FOG2, forms a transcription complex with GATA4; essential in tissue development and differentiation (heart, testis, mammary gland...). RUNX1 Location 21q22 Protein Transcription factor; role in normal hematopoiesis. References Chan EM, Comer EM, Brown FC, Richkind KE, Holmes ML, Chong BH, Shiffman R, Zhang DE, Slovak ML, Willman CL, Noguchi CT, Li Y, Heiber DJ, Kwan L, Chan RJ, Vance GH, Ramsey HC, Hromas RA. AML1-FOG2 fusion protein in myelodysplasia. Blood. 2005 Jun 1;105(11):4523-6 This article should be referenced as such: Huret JL. t(8;21)(q23;q22). Atlas Genet Cytogenet Oncol Haematol. 2009; 13(10):745. Atlas Genet Cytogenet Oncol Haematol. 2009; 13(10) 745